Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in active PsA and obesity.
The Well News on MSN
NTSB set to determine 'probable cause' of mid-air collision over Potomac
WASHINGTON - The National Transportation Safety Board has scheduled a public meeting for Jan. 27 at which it will announce ...
Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...
Prostate cancer causes around 12,000 deaths each year but the available tests are unreliable according to experts ...
The TOGETHER-PsA study shows that combining ixekizumab with tirzepatide leads to significantly better psoriatic arthritis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback